XVIVO Perfusion Appoints Lena Hagman as Deputy CEO

ACCESSWIRE

2024-11-14

GOTHENBURG, SWEDEN / ACCESSWIRE / November 14, 2024 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) The Board of Directors of XVIVO Perfusion AB (publ) ("XVIVO") has today appointed Lena Hagman as deputy CEO. She will remain in her role as COO.

Lena Hagman has been a member of XVIVO's management team since December 2022 and has a long career in the medical technology industry, with more than 20 years of global experience in leading positions with responsibility in R&D, supply chain and quality regulatory/medical affairs. Prior to joining XVIVO, Lena Hagman has held several leading roles in Swedish and global medical technology companies.

November 14, 2024
Mölndal, Sweden

The Board of Directors
XVIVO Perfusion AB (publ)

For further information, please contact:

Christoffer Rosenblad, CEO, +46 73 519 21 59, e-mail: christoffer.rosenblad@xvivogroup.com
Kristoffer Nordström, CFO, +46 73 519 21 64, e-mail: kristoffer.nordstrom@xvivogroup.com

About Us

Founded in 1998, XVIVO is the only medical technology company dedicated to extending the life of all major organs - so transplant teams around the world can save more lives. Our solutions allow leading clinicians and researchers to push the boundaries of transplantation medicine. XVIVO is headquartered in Gothenburg, Sweden, and has offices and research sites on two continents. The company is listed on Nasdaq Stockholm under the ticker symbol XVIVO. More information can be found on the website www.xvivogroup.com.

Attachments

XVIVO Perfusion appoints Lena Hagman as deputy CEO

SOURCE: XVIVO Perfusion AB

View the original press release on accesswire.com

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2483807455"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2483807455\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2483807455?lang=zh_TW&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/qiTeWLVv36_3LPJrPoWUTg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/1129bcc4fb3a617f29af1d2b235bb2c1","is_english":true,"pubTime":"2024-11-14 23:10","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2483807455","market":"us","top_or_hot":-1,"title":"XVIVO Perfusion Appoints Lena Hagman as Deputy CEO","media":"ACCESSWIRE","content":"<html><body><p><strong>GOTHENBURG, SWEDEN / ACCESSWIRE / November 14, 2024 / </strong>XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) The Board of Directors of XVIVO Perfusion AB (publ) (\"XVIVO\") has today appointed Lena Hagman as deputy CEO. She will remain in her role as COO.</p>\n<p>Lena Hagman has been a member of XVIVO's management team since December 2022 and has a long career in the medical technology industry, with more than 20 years of global experience in leading positions with responsibility in R&amp;D, supply chain and quality regulatory/medical affairs. Prior to joining XVIVO, Lena Hagman has held several leading roles in Swedish and global medical technology companies.</p>\n<p>November 14, 2024<br/>Mölndal, Sweden<br/></p>\n<p><i>The Board of Directors</i><br/>XVIVO Perfusion AB (publ)<br/></p>\n<p><strong>For further information, please contact:</strong></p>\n<p>Christoffer Rosenblad, CEO, +46 73 519 21 59, e-mail: christoffer.rosenblad@xvivogroup.com<br/>Kristoffer Nordström, CFO, +46 73 519 21 64, e-mail: kristoffer.nordstrom@xvivogroup.com<br/></p>\n<p><strong>About Us</strong></p>\n<p>Founded in 1998, XVIVO is the only medical technology company dedicated to extending the life of all major organs - so transplant teams around the world can save more lives. Our solutions allow leading clinicians and researchers to push the boundaries of transplantation medicine. XVIVO is headquartered in Gothenburg, Sweden, and has offices and research sites on two continents. The company is listed on Nasdaq Stockholm under the ticker symbol XVIVO. More information can be found on the website www.xvivogroup.com.</p>\n<p><strong>Attachments</strong></p>\n<p>XVIVO Perfusion appoints Lena Hagman as deputy CEO</p>\n<p><strong>SOURCE:</strong> XVIVO Perfusion AB</p>\n<br/>\n<br/>View the original \npress release on accesswire.com\n<br/>\n<br/>\n<br/>\n<br/>\n<br/></body></html>","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>XVIVO Perfusion Appoints Lena Hagman as Deputy CEO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nXVIVO Perfusion Appoints Lena Hagman as Deputy CEO\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">ACCESSWIRE</strong><span class=\"h-time small\">2024-11-14 23:10</span>\n</p>\n</h4>\n</header>\n<article>\n<html><body><p><strong>GOTHENBURG, SWEDEN / ACCESSWIRE / November 14, 2024 / </strong>XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) The Board of Directors of XVIVO Perfusion AB (publ) (\"XVIVO\") has today appointed Lena Hagman as deputy CEO. She will remain in her role as COO.</p>\n<p>Lena Hagman has been a member of XVIVO's management team since December 2022 and has a long career in the medical technology industry, with more than 20 years of global experience in leading positions with responsibility in R&amp;D, supply chain and quality regulatory/medical affairs. Prior to joining XVIVO, Lena Hagman has held several leading roles in Swedish and global medical technology companies.</p>\n<p>November 14, 2024<br/>Mölndal, Sweden<br/></p>\n<p><i>The Board of Directors</i><br/>XVIVO Perfusion AB (publ)<br/></p>\n<p><strong>For further information, please contact:</strong></p>\n<p>Christoffer Rosenblad, CEO, +46 73 519 21 59, e-mail: christoffer.rosenblad@xvivogroup.com<br/>Kristoffer Nordström, CFO, +46 73 519 21 64, e-mail: kristoffer.nordstrom@xvivogroup.com<br/></p>\n<p><strong>About Us</strong></p>\n<p>Founded in 1998, XVIVO is the only medical technology company dedicated to extending the life of all major organs - so transplant teams around the world can save more lives. Our solutions allow leading clinicians and researchers to push the boundaries of transplantation medicine. XVIVO is headquartered in Gothenburg, Sweden, and has offices and research sites on two continents. The company is listed on Nasdaq Stockholm under the ticker symbol XVIVO. More information can be found on the website www.xvivogroup.com.</p>\n<p><strong>Attachments</strong></p>\n<p>XVIVO Perfusion appoints Lena Hagman as deputy CEO</p>\n<p><strong>SOURCE:</strong> XVIVO Perfusion AB</p>\n<br/>\n<br/>View the original \npress release on accesswire.com\n<br/>\n<br/>\n<br/>\n<br/>\n<br/></body></html>\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"https://finance.yahoo.com/news/xvivo-perfusion-appoints-lena-hagman-151000380.html\">ACCESSWIRE</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"XVIPF","symbol_name":"Xvivo Perfusion AB","start_time":0,"source_url":"https://finance.yahoo.com/news/xvivo-perfusion-appoints-lena-hagman-151000380.html","article_id":"2483807455","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/qiTeWLVv36_3LPJrPoWUTg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/1129bcc4fb3a617f29af1d2b235bb2c1"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2483807455","pubTimestamp":1731597000,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"GOTHENBURG, SWEDEN / ACCESSWIRE / November 14, 2024 / XVIVO Perfusion AB  The Board of Directors of XVIVO Perfusion AB   has today appointed Lena Hagman as deputy CEO. She will remain in her role as COO.Lena Hagman has been a member of XVIVO's management team since December 2022 and has a long career in the medical technology industry, with more than 20 years of global experience in leading positions with responsibility in R&D, supply chain and quality regulatory/medical affairs. Prior to joining XVIVO, Lena Hagman has held several leading roles in Swedish and global medical technology companies.","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"XVIPF":"Xvivo Perfusion AB","XVIPY":"Xvivo Perfusion AB","BK4198":"医疗保健用品"},"translate_title":"XVIVO Perfusion任命Lena Hagman为副首席执行官","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XVIPF":0.9,"XVIPY":0.9},"content_text":"GOTHENBURG, SWEDEN / ACCESSWIRE / November 14, 2024 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) The Board of Directors of XVIVO Perfusion AB (publ) (\"XVIVO\") has today appointed Lena Hagman as deputy CEO. She will remain in her role as COO.\nLena Hagman has been a member of XVIVO's management team since December 2022 and has a long career in the medical technology industry, with more than 20 years of global experience in leading positions with responsibility in R&D, supply chain and quality regulatory/medical affairs. Prior to joining XVIVO, Lena Hagman has held several leading roles in Swedish and global medical technology companies.\nNovember 14, 2024Mölndal, Sweden\nThe Board of DirectorsXVIVO Perfusion AB (publ)\nFor further information, please contact:\nChristoffer Rosenblad, CEO, +46 73 519 21 59, e-mail: christoffer.rosenblad@xvivogroup.comKristoffer Nordström, CFO, +46 73 519 21 64, e-mail: kristoffer.nordstrom@xvivogroup.com\nAbout Us\nFounded in 1998, XVIVO is the only medical technology company dedicated to extending the life of all major organs - so transplant teams around the world can save more lives. Our solutions allow leading clinicians and researchers to push the boundaries of transplantation medicine. XVIVO is headquartered in Gothenburg, Sweden, and has offices and research sites on two continents. The company is listed on Nasdaq Stockholm under the ticker symbol XVIVO. More information can be found on the website www.xvivogroup.com.\nAttachments\nXVIVO Perfusion appoints Lena Hagman as deputy CEO\nSOURCE: XVIVO Perfusion AB\n\nView the original \npress release on accesswire.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}